search
epigenetic clocks
Trends
- 1Drugmakers say weight-loss drugs may slow biological aging●Weight-loss drugs show signs of slowing biological aging, say drugmakers
Eli Lilly and Novo Nordisk report that GLP-1 weight-loss drugs such as Ozempic and Wegovy appear to slow biological aging, based on epigenetic aging clocks. The claim, covered by MIT Technology Review, has drawn attention because it suggests the drugs' benefits may extend well beyond weight loss and diabetes treatment into longevity science, while experts caution the evidence is still early.
- 2
Biological aging clocks based on epigenetic markers have reportedly held up in a field test conducted in rural West Africa, according to coverage of the study. The finding suggests these aging measures, largely developed from data on Western populations, can perform accurately in a very different environment. It is seen as a step toward making epigenetic aging tools more broadly applicable in global health research.
- 3Epigenetic Clocks Remain Active in Brain Fluid After Bleeding Stroke●Epigenetic Clocks Stay Ticking in Brain Fluid After Bleeding Stroke
New findings indicate that epigenetic clocks — molecular markers used to estimate biological age — remain detectable in cerebrospinal fluid following a hemorrhagic stroke. The result suggests these aging markers stay active in the brain's fluid environment even after bleeding episodes, potentially offering a way to track biological aging and brain injury responses. Researchers and science commentators are discussing what this could mean for studying brain aging and recovery after stroke.